- Home
- IPHA vs CCLD Comparison
IPHA vs CCLD Comparison
Compare IPHA & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- CCLD
- Stock Information
- Founded
- IPHA 1999
- CCLD 1999
- Country
- IPHA France
- CCLD United States
- Employees
- IPHA N/A
- CCLD N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- CCLD Computer Software: Prepackaged Software
- Sector
- IPHA Health Care
- CCLD Technology
- Exchange
- IPHA Nasdaq
- CCLD Nasdaq
- Market Cap
- IPHA 160.1M
- CCLD 157.0M
- IPO Year
- IPHA 2019
- CCLD 2014
- Fundamental
- Price
- IPHA $2.05
- CCLD $3.35
- Analyst Decision
- IPHA Strong Buy
- CCLD Buy
- Analyst Count
- IPHA 1
- CCLD 2
- Target Price
- IPHA $11.00
- CCLD $3.00
- AVG Volume (30 Days)
- IPHA 14.6K
- CCLD 756.1K
- Earning Date
- IPHA 09-17-2025
- CCLD 11-11-2025
- Dividend Yield
- IPHA N/A
- CCLD N/A
- EPS Growth
- IPHA N/A
- CCLD N/A
- EPS
- IPHA N/A
- CCLD 0.00
- Revenue
- IPHA $14,839,695.00
- CCLD $111,794,000.00
- Revenue This Year
- IPHA $350.96
- CCLD $2.20
- Revenue Next Year
- IPHA $32.92
- CCLD $7.53
- P/E Ratio
- IPHA N/A
- CCLD $8,738.26
- Revenue Growth
- IPHA N/A
- CCLD 0.04
- 52 Week Low
- IPHA $1.29
- CCLD $1.14
- 52 Week High
- IPHA $3.51
- CCLD $4.84
- Technical
- Relative Strength Index (RSI)
- IPHA 46.87
- CCLD 52.44
- Support Level
- IPHA $1.93
- CCLD $3.35
- Resistance Level
- IPHA $2.19
- CCLD $3.98
- Average True Range (ATR)
- IPHA 0.11
- CCLD 0.23
- MACD
- IPHA -0.01
- CCLD -0.05
- Stochastic Oscillator
- IPHA 49.66
- CCLD 2.94
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About CCLD CareCloud Inc.
CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.